Practical advice on clinical decision making during neoadjuvant chemotherapy for primary breast cancer

H G Shenoy, M B Peter, Y A Masannat, B J G Dall, D Dodwell, K Horgan

Research output: Contribution to journalReview article

4 Citations (Scopus)


Neoadjuvant chemotherapy (NACT) is a useful approach in the treatment of many breast cancers. One of the main advantages of NACT is the possibility of breast conservation surgery in patients who would otherwise require a mastectomy. Most literature on NACT focuses on the effectiveness of different chemotherapy regimen and subsequent mastectomy rates. There is little guidance in the literature on aspects of individual patient management and decision making during NACT. This paper considers practical management advice where NACT is considered and adopted.

Original languageEnglish
Pages (from-to)65-71
Number of pages7
JournalEuropean Journal of Surgical Oncology
Issue number1
Early online date29 Aug 2008
Publication statusPublished - Mar 2009



  • Antineoplastic Agents/therapeutic use
  • Breast Neoplasms/drug therapy
  • Decision Making
  • Female
  • Humans
  • Neoadjuvant Therapy

Cite this